Continuum

OUR AIMS AND OBJECTIVES

We aim to discover via immuno-oncology

  Early cancer biomarkers
  How viruses can destroy cancer
  Broad spectrum cancer vaccinations
  Broad spectrum drugable cancer cures
  Individual cell based therapies

A UNIQUE AND FOCUSED APPROACH

  Research on extreme phenotypes’ blood and tissue
  Highly respected universities involved
  Highly respected professorial-lead teams (with industry leading knowledge and experience)
  Collaboration and sharing discoveries
  Links to major pharma and other cutting-edge research
  I.P. protected
  Minimal bureaucracy and maximum efficiency
  Use cutting edge technology

OUR AIMS AND OBJECTIVES

We aim to discover via immuno-oncology

  Early cancer biomarkers
  How viruses can destroy cancer
  Broad spectrum cancer vaccinations
  Broad spectrum drugable cancer cures
  Individual cell based therapies

A UNIQUE AND FOCUSED APPROACH

  Research on extreme phenotypes’ blood and tissue
  Highly respected universities involved
  Highly respected professorial-lead teams (with industry leading knowledge and experience)
  Collaboration and sharing discoveries
  Links to major pharma and other cutting-edge research
  I.P. protected
  Minimal bureaucracy and maximum efficiency
  Use cutting edge technology

OUR USP IS THAT WE KNOW WHERE TO LOOK

With an established cohort of cancer survivors (extreme phenotypes, exceptional responders, immunotherapy successes) as donors of blood, tissue and tumour, we are actively researching what it is that enables these rare individuals to survive. 

We are not using animals or in vitro experiments but will identify the successful factor(s) that cancer survivors (extreme phenotypes) hold within their bodies

THE FUTURE

  Future collaboration with institutions in the USA and mainland Europe

  Due to rapidity of immuno-oncology research, new machinery is required

  Drug trials / vaccinations

We at Continuum truly believe that our work will help millions of people around the globe.